Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Syndax Pharmaceuticals
Over the past year MLTX returned +14.1% and SNDX returned −31.9%; their daily moves had a correlation of 0.19.
MLTX +14.1% SNDX −31.9%Growth of $1, one year, split-adjusted
| Metric | MLTX | SNDX |
|---|---|---|
| Price | $11.56 | $10.45 |
| Market cap | $983.8M | $933.2M |
| Today | −1.20% | −26.87% |
| 1 month | +5.6% | −39.8% |
| 6 months | −34.7% | −49.4% |
| Year to date | −12.3% | −50.3% |
| 1 year | +13.3% | −24.1% |
| Revenue growth (YoY) | — | +81.6% |
| Gross margin | — | 83.2% |
| Net margin | — | −59.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $437.5M | $182.3M |
| Dividend yield | — | — |
| Volatility (60d) | 57.0% | 84.0% |
| Short % of float | 14.3% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).